title: Sclerotherapy and esophageal variceal bleeding: time to forget it, or not?
authors.forename: J
authors.initials: J
authors.lastname: Boix
authors.forename: V
authors.initials: V
authors.lastname: Lorenzo-Zúñiga
authors.forename: V
authors.initials: V
authors.lastname: Moreno de Vega
authors.forename: E
authors.initials: E
authors.lastname: Domènech
authors.forename: M A
authors.initials: MA
authors.lastname: Gassull
mesh_terms: D004359:Drug Therapy, Combination; D004638:Emergency Treatment; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage; D012189:Retrospective Studies; D015911:Sclerotherapy; D013004:Somatostatin / Q000008:administration & dosage
chemical_list: D000077423:Polidocanol; D011092:Polyethylene Glycols; D013004:Somatostatin